Achyut Healthcare Ltd
₹6.02▲ +0.28 (+4.88%)
ACHYUT·BSE·Healthcare
Market Cap
145.30 Cr
PE Ratio
602.00
Volume
2,65,372
Day High - Low
6.02 - 6.02
52W High-Low
10.04 - 4.70
₹6.02▲ +0.28 (+4.88%)
Market Cap145.30 Cr
PE Ratio602.00
Volume2,65,372
Day High - Low6.02 - 6.02
52W High-Low10.04 - 4.70
Achyut Healthcare Ltd (ACHYUT): company summary
The company's revenue surged 280.0% annually, but net profit remained at ₹0 crore, with a net profit margin that fell 15.2 percentage points to 2.7%.
Achyut Healthcare Ltd (ACHYUT) is a micro-cap Healthcare company valued at ₹145 crore operating in Pharmaceuticals on the NSE and BSE.
- Recent price move
- Achyut Healthcare Ltd last traded at ₹6.02, up 4.88% on the day.
- Financial performance
- The company's revenue surged 280.0% annually, but net profit remained at ₹0 crore, with a net profit margin that fell 15.2 percentage points to 2.7%. The latest quarter saw revenue rise 1.3% year-over-year, while net profit stayed flat at ₹0 crore.
- Valuation multiples
- The stock trades at 602.0 times earnings, a premium to the Healthcare median of 32.0, 4.81 times book value.
- Things to watch
- The company reported an annual net profit of ₹0 crore, a sharp decline of 41.8% from the prior year. The net profit margin has dropped significantly to 2.7%, down 15.2 percentage points from 18.0% a year ago. The stock is 42.8% below its 52-week high.
- Where it stands
- Achyut Healthcare Ltd has seen rapid revenue growth, but net profit remains at zero. The company's net profit margin has deteriorated sharply, and the stock is significantly below its recent high. The most notable movement is the steep drop in net profit margin.
Summarised by DocStoX's model on 2026-10-18 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
DocStoX Score
3.6/10
Poor
Fair Value
Sign in to see
ROE
0.90%
Weak
P/E
602.00x
Expensive
Debt / Equity
0.04
Low
Industry
Healthcare
Pharmaceuticals
Overall View
Mixed
Price performance
52W₹4.70
₹10.04
DocStoX take
Supported by growth (7.5) and risk (6.7), but held back by valuation (0.0). Growth looks strong at 7.5, but that is offset by valuation at 0.0 and momentum at 1.4 and quality at 2.2. We are calling it Mixed rather than resolving the conflict for you.
DocStoX score
Low confidence3.6
/10
Poor
Quality
Weak
ROE 0.9%
Valuation
Expensive
P/E 200.0×
Growth
Strong
Revenue +112.1% 5Y CAGR
Risk
Moderate
D/E 0.04
Momentum
Weak
25% of 52-week range
At a glance
Market Cap
₹145 Cr
52W High / Low
₹10 / ₹5
Dividend Yield
0.00%
Promoter Holding
47.32%
EPS (TTM)
₹0.01
Book Value
₹1.45
Key highlights
- Revenue compounding 112% a year
- Profit compounding 100% a year
- Low leverage — D/E 0.04
- Quality is weak (2.2/10)
- Valuation is weak (0.0/10)
4 Positives4 Watchouts
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Healthcare stocks · Pharmaceuticals
Explore Achyut Healthcare Ltd’s valuation
Free deep-dive tools · no sign-up
Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.
Achyut Healthcare Ltd peers in Healthcare
Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.
SUN PHARMACEUTICAL IND LDIVI S LABORATORIES LTDTORRENT PHARMACEUTICALS LLAURUS LABS LIMITEDZYDUS LIFESCIENCES LTDAPOLLO HOSPITALS ENTER. LCIPLA LTDDR. REDDY S LABORATORIESAUROBINDO PHARMA LTDMANKIND PHARMA LIMITEDLUPIN LIMITEDMANIPAL HEALTH ENTERPRI L
Compare Achyut Healthcare Ltd with peers
Related tools & concepts
Value Achyut Healthcare Ltd with the ratios and calculators DocStoX uses in its analysis.
P/E RatioPrice to earningsReturn on Equity (ROE)ProfitabilityROCECapital efficiencyDebt to EquityLeverageP/B RatioPrice to bookNet Profit MarginBottom-line efficiencyDCF / Intrinsic ValueEstimate fair valueCAGR CalculatorAnnualised returnDividend YieldIncome on pricePosition SizeRisk-based sizingBrokerage CalculatorCharges on a tradeSIP CalculatorSystematic investing